USFDA approval of Eucrisa for eczema
Brand Name: Eucrisa Molecule: Crisaborole Class: phosphodiesterase 4 (PDE-4) inhibitor Manufactured By: Anacor Pharmaceuticals, Inc. ———————————————————- The U.S. Food and Drug Administration today... Read More
Pfizer completes acquisitions of Anacor
Pfizer Inc. completed its acquisition of Anacor Pharmaceuticals, Inc. According to the company, the transaction terms provided each outstanding share of Anacor... Read More
Pfizer’s Acquisition of Anacor: Pfizer to get lead asset in derma
Posted on17 May 2016
Tagsanacor, atopic dermatitis, crisaborole, PDE-4 inhibitor, pfizer, Pfizer anacor deal, Pfizer's Acquisition of Anacor
Comments0
Pfizer will acquire Anacor for a total transaction value of $5.2bn (which assumes the conversion of Anacor’s convertible notes). Why this acquisition?... Read More